Laura M. Handel

981 total citations
13 papers, 812 citations indexed

About

Laura M. Handel is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Laura M. Handel has authored 13 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Reproductive Medicine. Recurrent topics in Laura M. Handel's work include Ovarian cancer diagnosis and treatment (5 papers), Cancer therapeutics and mechanisms (2 papers) and DNA and Nucleic Acid Chemistry (2 papers). Laura M. Handel is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Cancer therapeutics and mechanisms (2 papers) and DNA and Nucleic Acid Chemistry (2 papers). Laura M. Handel collaborates with scholars based in United States. Laura M. Handel's co-authors include Thomas C. Hamilton, Andrew K. Godwin, Raymond P. Perez, Robert F. Ozols, Steven W. Johnson, T C Hamilton, Joseph R. Testa, Lisa Vanderveer, LEOTA HALL and Albert J. Fornace and has published in prestigious journals such as Molecular and Cellular Biology, JNCI Journal of the National Cancer Institute and International Journal of Cancer.

In The Last Decade

Laura M. Handel

13 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura M. Handel United States 11 444 335 208 100 94 13 812
T C Hamilton United States 10 431 1.0× 314 0.9× 181 0.9× 122 1.2× 96 1.0× 14 781
Alfred M. Rogan Austria 5 607 1.4× 440 1.3× 131 0.6× 90 0.9× 72 0.8× 6 1.0k
Gary L. Goldberg United States 17 416 0.9× 303 0.9× 183 0.9× 108 1.1× 61 0.6× 33 867
Minshu Yu United States 20 541 1.2× 516 1.5× 178 0.9× 155 1.6× 73 0.8× 37 959
Tsuyoshi Okuda Japan 12 370 0.8× 258 0.8× 187 0.9× 172 1.7× 109 1.2× 15 733
Xiuxian Jiang United Kingdom 7 227 0.5× 103 0.3× 339 1.6× 59 0.6× 64 0.7× 8 635
Jeffrey D. Bray United States 12 441 1.0× 139 0.4× 116 0.6× 56 0.6× 68 0.7× 20 885
Verena Materna Germany 20 552 1.2× 632 1.9× 155 0.7× 220 2.2× 99 1.1× 33 1.1k
Bridget A. Quinn United States 16 454 1.0× 408 1.2× 85 0.4× 110 1.1× 63 0.7× 24 965
Maree Bilandzic Australia 17 391 0.9× 351 1.0× 196 0.9× 157 1.6× 41 0.4× 29 884

Countries citing papers authored by Laura M. Handel

Since Specialization
Citations

This map shows the geographic impact of Laura M. Handel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura M. Handel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura M. Handel more than expected).

Fields of papers citing papers by Laura M. Handel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura M. Handel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura M. Handel. The network helps show where Laura M. Handel may publish in the future.

Co-authorship network of co-authors of Laura M. Handel

This figure shows the co-authorship network connecting the top 25 collaborators of Laura M. Handel. A scholar is included among the top collaborators of Laura M. Handel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura M. Handel. Laura M. Handel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Perez, Raymond P., Steven W. Johnson, Laura M. Handel, Peter J. O’Dwyer, & Thomas C. Hamilton. (1995). Determinants of Cisplatin Sensitivity in Normal versus Spontaneously Transformed Rat Ovarian Surface Epithelial Cells. Gynecologic Oncology. 58(3). 312–318. 3 indexed citations
2.
Testa, Joseph R., Lori Getts, H Salazar, et al.. (1994). Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity.. PubMed. 54(10). 2778–84. 91 indexed citations
3.
Johnson, Steven W., Raymond P. Perez, Andrew K. Godwin, et al.. (1994). Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochemical Pharmacology. 47(4). 689–697. 98 indexed citations
4.
Johnson, Steven W., et al.. (1994). Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.. PubMed. 54(22). 5911–6. 115 indexed citations
5.
Perez, Raymond P., Andrew K. Godwin, Laura M. Handel, & Thomas C. Hamilton. (1993). A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. European Journal of Cancer. 29(3). 395–399. 63 indexed citations
6.
Perez, Raymond P., et al.. (1993). Transformation of rat ovarian epithelial and Rat-1 fibroblast cell lines by RAST24 does not influence cisplatin sensitivity.. PubMed. 53(16). 3771–5. 16 indexed citations
7.
Perez, Raymond P., Laura M. Handel, & Thomas C. Hamilton. (1992). Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitor. Gynecologic Oncology. 46(1). 82–87. 15 indexed citations
8.
Godwin, Andrew K., et al.. (1992). Spontaneous Transformation of Rat Ovarian Surface Epithelial Cells: Association With Cytogenetic Changes and Implications of Repeated Ovulation in the Etiology of Ovarian Cancer. JNCI Journal of the National Cancer Institute. 84(8). 592–601. 143 indexed citations
9.
Perez, Raymond P., et al.. (1992). In vitro interactions between platinum analogues in human ovarian-carcinoma cell lines. Cancer Chemotherapy and Pharmacology. 29(6). 430–434. 21 indexed citations
10.
Perez, Raymond P., Peter J. O’Dwyer, Laura M. Handel, Robert F. Ozols, & Thomas C. Hamilton. (1991). Comparative cytotoxicity of CI‐973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines. International Journal of Cancer. 48(2). 265–269. 40 indexed citations
11.
Schilder, Russell J., LEOTA HALL, Anne Monks, et al.. (1990). Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. International Journal of Cancer. 45(3). 416–422. 153 indexed citations
12.
Warren, Stephen L., Laura M. Handel, & W. James Nelson. (1988). Elevated Expression of pp60 c- src Alters a Selective Morphogenetic Property of Epithelial Cells In Vitro without a Mitogenic Effect. Molecular and Cellular Biology. 8(2). 632–646. 9 indexed citations
13.
Warren, Stephen L., Laura M. Handel, & W. James Nelson. (1988). Elevated expression of pp60c-src alters a selective morphogenetic property of epithelial cells in vitro without a mitogenic effect.. Molecular and Cellular Biology. 8(2). 632–646. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026